Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.09+0.06 (+0.37%)
At close: 4:00PM EDT
16.09 0.00 (0.00%)
After hours: 04:01PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/19/2021
Current
6/30/20213/31/202112/31/20209/30/2020
Market Cap (intraday) 5
981.29M1.07B1.31B291.86M110.30M
Enterprise Value 3
760.99M957.78M1.27B249.58M53.36M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
115.29114.60165.3845.3019.34
Price/Book (mrq)
4.209.5734.867.162.23
Enterprise Value/Revenue 3
114.78525.10714.45157.9636.83
Enterprise Value/EBITDA 7
-15.10-73.91-107.57-18.41-5.40

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3254.65%
S&P500 52-Week Change 330.30%
52 Week High 330.38
52 Week Low 33.04
50-Day Moving Average 317.40
200-Day Moving Average 319.12

Share Statistics

Avg Vol (3 month) 3416.95k
Avg Vol (10 day) 3308.32k
Shares Outstanding 561.22M
Implied Shares Outstanding 6N/A
Float 844.12M
% Held by Insiders 13.93%
% Held by Institutions 192.17%
Shares Short (Sep 29, 2021) 43.22M
Short Ratio (Sep 29, 2021) 45.91
Short % of Float (Sep 29, 2021) 46.17%
Short % of Shares Outstanding (Sep 29, 2021) 45.26%
Shares Short (prior month Aug 30, 2021) 42.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-734.47%

Management Effectiveness

Return on Assets (ttm)-16.32%
Return on Equity (ttm)-50.27%

Income Statement

Revenue (ttm)6.63M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)-10.90%
Gross Profit (ttm)-27.99M
EBITDA -48.02M
Net Income Avi to Common (ttm)-71.17M
Diluted EPS (ttm)-1.48
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)231.67M
Total Cash Per Share (mrq)3.79
Total Debt (mrq)13.94M
Total Debt/Equity (mrq)5.96
Current Ratio (mrq)16.17
Book Value Per Share (mrq)3.82

Cash Flow Statement

Operating Cash Flow (ttm)-45.46M
Levered Free Cash Flow (ttm)-28.78M
Advertisement
Advertisement